Microbot Medical Inc. showcased its LIBERTY® Endovascular Robotic System at the International Symposium on Endovascular Therapy (ISET) conference held in Miami Beach, Florida, from February 9-12, 2026. During the event, the company participated in a Town Hall session focused on the future of endovascular robotics, where the LIBERTY System—currently the only FDA-cleared, single-use endovascular robotic system—was prominently featured. The system’s integration into clinical workflows and its role in advancing peripheral endovascular intervention were discussed by leading interventional specialists. This exposure is part of LIBERTY’s limited market release in the US, with plans for a full market launch later in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9653658-en) on February 12, 2026, and is solely responsible for the information contained therein.